FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952851640> ?p ?o ?g. }

• W2952851640 endingPage "e028243" @default.
• W2952851640 startingPage "e028243" @default.
• W2952851640 abstract "Introduction Fetal growth restriction (FGR) is a serious pregnancy complication, associated with increased rates of perinatal death and morbidity among survivors. Most commonly FGR results from placental insufficiency, where the placenta fails to deliver the oxygen and nutrients required for normal fetal growth. This leads to fetal oxidative stress, resulting in organ damage through lipid peroxidation. The early developing brain is particularly susceptible, such that FGR is associated with poorer neurodevelopment, witnessed as cognitive and behavioural dysfunction, and cerebral palsy. Promisingly, melatonin, a lipid soluble antioxidant is neuroprotective in animal models of FGR. We present a protocol outlining a randomised, placebo-controlled trial to explore whether antenatal maternal melatonin supplementation in pregnancies with severe, early-onset FGR can improve neurodevelopment among survivors at 2 years of age. Methods and analyses We will recruit 336 women with a singleton pregnancy complicated by FGR between 23+0 and 31+6 weeks gestation. Participants will be randomised, stratified by gestational age, to either 30 mg melatonin per day or a visually identical placebo, continued until birth. Measures of maternal and fetal health will be collected until birth. Timing of birth will be determined by the treating clinical team in discussion with the woman. Neonatal and infant neurodevelopmental assessments will be undertaken, consisting of brain MRI at term corrected age, general movements assessment at term and 3 months’ corrected age, and Bayley Scales of Infant & Toddler Development-III and Infant Toddler Social Emotional Assessment at 2.5 years corrected age. Analyses will be on intention to treat. The primary outcome is a difference of 5 points in the cognitive domain of the Bayley-III. Secondary outcomes address maternal and fetal safety. Ethics and dissemination This trial has Monash Health Human Research and Ethics committee approval (17-0000-583A). Findings will be disseminated through peer-reviewed publications, conference presentations and to participants. Trial registration number ACTRN12617001515381; Pre-results" @default.
• W2952851640 created "2019-06-27" @default.
• W2952851640 creator A5002146254 @default.
• W2952851640 creator A5008343091 @default.
• W2952851640 creator A5013570044 @default.
• W2952851640 creator A5032226344 @default.
• W2952851640 creator A5052324333 @default.
• W2952851640 creator A5063001635 @default.
• W2952851640 creator A5063008596 @default.
• W2952851640 creator A5066966783 @default.
• W2952851640 creator A5091880471 @default.
• W2952851640 date "2019-06-01" @default.
• W2952851640 modified "2023-10-18" @default.
• W2952851640 title "Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction" @default.
• W2952851640 cites W151105582 @default.
• W2952851640 cites W1643783077 @default.
• W2952851640 cites W1757974377 @default.
• W2952851640 cites W1970323972 @default.
• W2952851640 cites W1992880777 @default.
• W2952851640 cites W2011285698 @default.
• W2952851640 cites W2019033274 @default.
• W2952851640 cites W2021427246 @default.
• W2952851640 cites W2026465193 @default.
• W2952851640 cites W2029459733 @default.
• W2952851640 cites W2032784868 @default.
• W2952851640 cites W2038026546 @default.
• W2952851640 cites W2039503336 @default.
• W2952851640 cites W2042439800 @default.
• W2952851640 cites W2050845796 @default.
• W2952851640 cites W2051580911 @default.
• W2952851640 cites W2053497190 @default.
• W2952851640 cites W2059629816 @default.
• W2952851640 cites W2079192915 @default.
• W2952851640 cites W2080432837 @default.
• W2952851640 cites W2098619885 @default.
• W2952851640 cites W2124856858 @default.
• W2952851640 cites W2141732795 @default.
• W2952851640 cites W2158512558 @default.
• W2952851640 cites W2171811563 @default.
• W2952851640 cites W2176374714 @default.
• W2952851640 cites W2323015755 @default.
• W2952851640 cites W2512558889 @default.
• W2952851640 cites W2519262228 @default.
• W2952851640 cites W2593414536 @default.
• W2952851640 cites W2611683709 @default.
• W2952851640 cites W2771670745 @default.
• W2952851640 cites W2790251179 @default.
• W2952851640 cites W2804156855 @default.
• W2952851640 cites W2808340851 @default.
• W2952851640 cites W2887780861 @default.
• W2952851640 doi "https://doi.org/10.1136/bmjopen-2018-028243" @default.
• W2952851640 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6596968" @default.
• W2952851640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31230020" @default.
• W2952851640 hasPublicationYear "2019" @default.
• W2952851640 type Work @default.
• W2952851640 sameAs 2952851640 @default.
• W2952851640 citedByCount "21" @default.
• W2952851640 countsByYear W29528516402019 @default.
• W2952851640 countsByYear W29528516402020 @default.
• W2952851640 countsByYear W29528516402021 @default.
• W2952851640 countsByYear W29528516402022 @default.
• W2952851640 countsByYear W29528516402023 @default.
• W2952851640 crossrefType "journal-article" @default.
• W2952851640 hasAuthorship W2952851640A5002146254 @default.
• W2952851640 hasAuthorship W2952851640A5008343091 @default.
• W2952851640 hasAuthorship W2952851640A5013570044 @default.
• W2952851640 hasAuthorship W2952851640A5032226344 @default.
• W2952851640 hasAuthorship W2952851640A5052324333 @default.
• W2952851640 hasAuthorship W2952851640A5063001635 @default.
• W2952851640 hasAuthorship W2952851640A5063008596 @default.
• W2952851640 hasAuthorship W2952851640A5066966783 @default.
• W2952851640 hasAuthorship W2952851640A5091880471 @default.
• W2952851640 hasBestOaLocation W29528516401 @default.
• W2952851640 hasConcept C103728769 @default.
• W2952851640 hasConcept C118552586 @default.
• W2952851640 hasConcept C126322002 @default.
• W2952851640 hasConcept C138496976 @default.
• W2952851640 hasConcept C142724271 @default.
• W2952851640 hasConcept C15744967 @default.
• W2952851640 hasConcept C164953862 @default.
• W2952851640 hasConcept C168563851 @default.
• W2952851640 hasConcept C169900460 @default.
• W2952851640 hasConcept C172680121 @default.
• W2952851640 hasConcept C1862650 @default.
• W2952851640 hasConcept C187212893 @default.
• W2952851640 hasConcept C204787440 @default.
• W2952851640 hasConcept C25498285 @default.
• W2952851640 hasConcept C27081682 @default.
• W2952851640 hasConcept C2778182776 @default.
• W2952851640 hasConcept C2778242525 @default.
• W2952851640 hasConcept C2778376644 @default.
• W2952851640 hasConcept C2778780700 @default.
• W2952851640 hasConcept C2779234561 @default.
• W2952851640 hasConcept C2779421357 @default.
• W2952851640 hasConcept C46973012 @default.
• W2952851640 hasConcept C535046627 @default.
• W2952851640 hasConcept C54355233 @default.
• W2952851640 hasConcept C71924100 @default.

• next